Pls Refer the Attachment
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Smallcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre's Board approved audited standalone and consolidated financial results for Q4 and FY ended March 2026. The Board recommended a final dividend of ₹2 per share (200% on ₹1 face value), subject to shareholder approval at the AGM. Dr. D Nageshwar Reddy will not seek re-appointment for a second term as Independent Director due to pre-occupation and other professional commitments. The company granted 1,79,500 ESOPs at ₹784 per option (average price with 20% discount) to eligible employees under VDCL ESOP Plan 2018. Additionally, the company approved acquisition of MRI, EEG and NCV Services Business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore in cash. This acquisition is classified as a Related Party Transaction.
The dividend declaration and ESOP grants are positive signals for shareholders and employee retention. The related party acquisition from a wholly-owned subsidiary streamlines the business structure. The departure of Dr. D Nageshwar Reddy removes a key independent director from the board.